- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| ALKT | ALKAMI TECHNOLOGY INC | 1.71% | 600,284 | $10,877,146 | 600,284 | New | $18.12 | 13F |
| CELC | CELCUITY INC | 1.06% | 64,110 | $6,707,188 | 64,110 | New | $104.62 | 13F |
| RARE | ULTRAGENYX PHARMACEUTICAL IN (Call) | 0.53% | 100,000 | $3,339,000 | 100,000 | New | $33.39 | 13F |
| SLN | SILENCE THERAPEUTICS PLC (Call) | 0.52% | 300,000 | $3,294,000 | 300,000 | New | $10.98 | 13F |
| CUE | CUE BIOPHARMA INC | 0.47% | 93,819 | $2,960,928 | 93,819 | New | $31.56 | 13F |
| ACRS | ACLARIS THERAPEUTICS INC | 0.33% | 400,000 | $2,116,000 | 400,000 | New | $5.29 | 13F |
| AGIO | AGIOS PHARMACEUTICALS INC (Call) | 0.29% | 50,000 | $1,855,500 | 50,000 | New | $37.11 | 13F |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.21% | 56,052 | $1,356,458 | 56,052 | New | $24.2 | 13F |
| TENX | TENAX THERAPEUTICS INC (Call) | 0.17% | 75,100 | $1,092,705 | 75,100 | New | $14.55 | 13F |
| AMLX | AMYLYX PHARMACEUTICALS INC (Call) | 0.02% | 8,500 | $152,660 | 8,500 | New | $17.96 | 13F |